Stay updated on NSCLC Immunotherapy Clinical Trial

Sign up to get notified when there's something new on the NSCLC Immunotherapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NSCLC Immunotherapy Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A sitewide NIH notice announces a terminology transition, saying that “Super Intelligence” may appear in place of “Artificial Intelligence” across NIH content.
    Difference
    1%
    Check dated 2026-10-23T12:25:08.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.1 to v3.7.2, while the study record remains inaccessible behind a 403 error.
    Difference
    0.2%
    Check dated 2026-10-16T14:40:23.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.0 to v3.7.1, while the page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-09T15:32:39.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The page displays a 403 Forbidden error, replacing the study content with an access-denied message. This means users cannot view the trial details and related information on this page.
    Difference
    18%
    Check dated 2026-09-25T17:47:56.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.6.6 to v3.7.0, indicating a newer version of the page content.
    Difference
    0.0%
    Check dated 2026-09-18T18:56:16.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The trial's location list was updated to drop Qiryat Krinitzi and add Tel Litwinsky in Israel, altering the set of active recruitment sites. This reflects a change in where eligible patients can enroll in the study.
    Difference
    0.0%
    Check dated 2026-09-11T16:32:05.000Z thumbnail image

Stay in the know with updates to NSCLC Immunotherapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NSCLC Immunotherapy Clinical Trial page.